Tag: Novartis

All

FDA Approves Novartis’ New IL-17A-Blocking Psoriasis Drug Cosentyx

Novartis' Cosentyx is the first approved human monoclonal antibody that selectively binds to interleukin IL-17A.

Odomzo Gets FDA Nod for Locally Advanced BCC
Global Eczema Treatment Market To Double in Value by 2024

All

Sorry, No Posts Found

All

First U.S. Women Receive Breast Augmentation with FDA-Approved Motiva Implants

Establishment Labs Holdings Inc, a global medical technology company specializing in women’s health, announces the first U.S. breast augmentations using Motiva Implants.

Scott Hollenbeck, MD, Named ASPS President
The Plastic Surgery Foundation Names Alan Matarasso, MD, FACS, President
New Tool Prepares Breast Cancer Patients for Reconstruction Decisions

Tag: Novartis

All

FDA Approves Novartis’ New IL-17A-Blocking Psoriasis Drug Cosentyx

Odomzo Gets FDA Nod for Locally Advanced BCC

Global Eczema Treatment Market To Double in Value by 2024

All

Sorry, No Posts Found

All

First U.S. Women Receive Breast Augmentation with FDA-Approved Motiva Implants

Scott Hollenbeck, MD, Named ASPS President

The Plastic Surgery Foundation Names Alan Matarasso, MD, FACS, President

New Tool Prepares Breast Cancer Patients for Reconstruction Decisions

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links